Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Z. Machackova"'
Autor:
Fjodor Melnikov, Chunze Li, Whitney P. Kirschbrown, Tong Lu, Jin Y. Jin, Eleonora Restuccia, Tanja Badovinac Crnjevic, Z. Machackova, Sandhya Girish, Stephanie N. Liu
Publikováno v:
Journal of Clinical Pharmacology
PERJETA (pertuzumab), administered with Herceptin (trastuzumab), is used in the treatment of human epidermal growth factor receptor 2‐positive breast cancer. Pertuzumab is currently approved with an initial loading dose of 840 mg, followed by a 420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c6c91f2d7951cfbaff947505566724
http://europepmc.org/articles/PMC8361934
http://europepmc.org/articles/PMC8361934
Autor:
J. O'Shaughnessy, S.P. Sousa, J. Cruz Jurado, L.J. Fallowfield, P. Auvinen, C. Pulido, A.S. Cvetanovic, S.T. Wilks, L.A. Ribeiro, M. Burotto, T. Boulet, V. Revelant, N. Theron, P. Trask, L.A. Wahyudi, Z. Machackova, L. Stamatovic
Publikováno v:
ESMO Open. 8:101321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::632b86bff828b73960a08a02cefdb95b
https://doi.org/10.1016/j.esmoop.2023.101321
https://doi.org/10.1016/j.esmoop.2023.101321
Autor:
Sara M. Tolaney, Michael Untch, Joseph Gligorov, Edith A. Perez, Andrew M Wardley, Andreas Schneeweiss, Christian Jackisch, Charles E. Geyer, Patricia Cortazar, Z. Machackova, Luca Gianni, Martine Piccart
Publikováno v:
Cancer treatment reviews, 99
Treatment of HER2-positive early breast cancer (EBC) continues to evolve with neoadjuvant (pre-operative) and adjuvant (post-operative) HER2-targeted therapies as standard of care. There are two important decision points. The first involves deciding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538625d1725dd36567bc964d2e760d31
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/326902
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/326902
Autor:
Mauricio Burotto, C. Pulido, A. Cvetanovic, Sharon Wilks, Josefina Cruz, S.P. Sousa, Z. Machackova, Peter Trask, Lesley Fallowfield, Joyce O'Shaughnessy, L. Stamatovic, Judy Fredriksson, Dimitri Messeri, A. Alexandrou, Leonor Ribeiro, Dirk Klingbiel, P. Auvinen
Publikováno v:
Annals of Oncology. 31:S306-S307
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dff9042219324164381911a5efa0d1f9
https://doi.org/10.1016/j.annonc.2020.08.287
https://doi.org/10.1016/j.annonc.2020.08.287
Autor:
Valerie Jenkins, S. Lauer, Ann Knoop, Giuseppe Curigliano, Xavier Pivot, Volkmar Müller, Sunil Verma, Lesley Fallowfield, Joseph Gligorov, Z. Machackova, S. Osborne
Aim: To assess the safety and tolerability of switching between subcutaneous (SC) and intravenous (IV) trastuzumab in the PrefHer study (NCT01401166).\ud \ud Patients and methods: Patients with HER2-positive early breast cancer completed (neo)adjuvan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b6747d3fbeee86dad83b7cc2be7a4b
Autor:
X. Pivot, Z. Machackova
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 26(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f16d0dd5fc0daca320a21f3bb52d72
https://pubmed.ncbi.nlm.nih.gov/25787921
https://pubmed.ncbi.nlm.nih.gov/25787921
Publikováno v:
Value in Health. 19:A713
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4cfaf76ede1398f359e5d4a77577aa5
https://doi.org/10.1016/j.jval.2016.09.2102
https://doi.org/10.1016/j.jval.2016.09.2102
Autor:
Xavier Pivot, M. Martin, Z. Machackova, C. Poole, A.J. ten Tije, Luca Gianni, Eduard Vrdoljak, Carlos Barrios, M. Truman, Joseph Gligorov, Günther G. Steger
Publikováno v:
Annals of Oncology. 27:vi63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbedc87583836611d2f5b48297c82c39
https://doi.org/10.1093/annonc/mdw364.66
https://doi.org/10.1093/annonc/mdw364.66
Autor:
S. Osborne, Volkmar Müller, Joseph Gligorov, A. Sánchez Muñoz, Sunil Verma, Lesley Fallowfield, Z. Machackova, Mikhail Lichinitser, Xavier Pivot
Publikováno v:
Annals of Oncology. 27:vi63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d751570338fbfc10e5ae2ab3cfc749
https://doi.org/10.1093/annonc/mdw364.65
https://doi.org/10.1093/annonc/mdw364.65
Publikováno v:
Neoplasma. 55(3)
The reliability of a particular in vitro parameter as potential prognostic biomarker of individual radiosensitivity is still discussed. Therefore, several in vitro radiation-induced cellular endpoints including initial, oxidative and residual DNA dam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62719483d77f4ef0305f5fe62fb37e9b
https://pubmed.ncbi.nlm.nih.gov/18348650
https://pubmed.ncbi.nlm.nih.gov/18348650